Perrigo Gets FDA Approval For Morphine Sulfate 100ml/5% Oral Solution

Perrigo Receives Approval For Generic Version Of Sanctura XR - Quick Facts

Perrigo Profit Q3 Profit Declines - Update

Perrigo Co. Q3 13 Earnings Conference Call At 10:00 AM ET

Perrigo Q3 Profit Down, Adj.EPS Misses View, Backs FY13 View - Quick Facts

Trade PRGO now with

8/8/2012 9:51 AM ET

Perrigo Co. (PRGO: Quote) said it has received final approval from the FDA for its abbreviated new drug application for morphine sulfate 100ml/5% oral solution. Perrigo will commence shipment of the product immediately.

Morphine sulfate oral solution, a Schedule II controlled substance, is indicated for the relief of moderate to severe acute and chronic pain where use of an opioid analgesic is appropriate. Generic annual sales were approximately $26 million, as measured by Wolters Kluwer Health.

Click here to receive FREE breaking news email alerts for Perrigo Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 67 Articles

Editors Pick

China Manufacturing Contraction Deepens In June

China's manufacturing activity contracted at a faster pace in June, reducing the prospects of a promising economic recovery, preliminary results of a survey by Markit Economics and HSBC revealed Thursday. The flash manufacturing purchasing managers' index fell to 48.3 in June from 49.2 in May. The index is now at its lowest level in nine months.

King Makes Last Plea For Stimulus Before Entrusting BoE To Carney's 'Safe Hands'

Bank of England Governor Mervyn King made a last but strong call for expanding stimulus for the British economy in his final Mansion House speech on Wednesday even as he left some "unfinished business" in the banking sector for the next chief Mark Carney to complete. King will step down by end-June after ten years at the helm. Carney will assume office from July 1.

Red Hat Results Edge Past Estimates

Red Hat Inc., the world's largest seller of Linux software, said Wednesday after the markets closed that its first quarter profit rose 8% from last year, as revenue increased 15% amid strong consumer demand. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations as did its quarterly revenue.